Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TXMD TherapeuticsMD Inc

0.0001 (0.00%)
Last Updated: 15:12:21
Delayed by 15 minutes


Draw Mode:

Volume 12,158
Bid Price 2.37
Ask Price 2.40
News -
Day High 2.4078


52 Week Range


Day Low 2.29
Company Name Stock Ticker Symbol Market Type
TherapeuticsMD Inc TXMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0001 0.00% 2.3701 15:12:21
Open Price Low Price High Price Close Price Prev Close
2.38 2.29 2.4078 2.37
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
324 12,158 $ 2.35 $ 28,552 - 1.95 - 5.03
Last Trade Time Type Quantity Stock Price Currency
15:35:42 1 $ 2.40 USD

TherapeuticsMD Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
25.27M 10.58M - 69.96M 112M 10.59 0.23
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

TherapeuticsMD News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No TXMD Message Board. Create One! See More Posts on TXMD Message Board See More Message Board Posts

Historical TXMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.252.40782.222.3121,9990.12015.34%
1 Month2.292.40782.2172.2913,9740.08013.50%
3 Months2.302.502.012.2819,7000.07013.05%
6 Months3.853.9551.952.5419,767-1.48-38.44%
1 Year4.905.031.953.3926,127-2.53-51.63%
3 Years1.5911.690.15031.122,968,8110.780149.06%
5 Years5.8311.690.15031.623,674,925-3.46-59.35%

TherapeuticsMD Description

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.

Your Recent History

Delayed Upgrade Clock